About CytunePharma
CytunePharma is a company based in Nantes (France) founded in 2007 was acquired by Sotio in August 2018.. CytunePharma has raised $7.84 million across 3 funding rounds from investors including SOTIO, PPF Group and Starquest Capital. CytunePharma operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others.
- Headquarter Nantes, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CytunePharma
CytunePharma has successfully raised a total of $7.84M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $6.6 million completed in June 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $6.6M
-
First Round
First Round
(01 Jun 2012)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2016 | Amount | Series B - CytunePharma | Valuation |
investors |
|
| Feb, 2015 | Amount | Series A - CytunePharma | Valuation |
investors |
|
| Jun, 2012 | Amount | Seed - CytunePharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CytunePharma
CytunePharma has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include SOTIO, PPF Group and Starquest Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PPF Group is engaged in international investment across diverse sectors.
|
Founded Year | Domain | Location | |
|
Investments in Europe and US are made by Starquest Capital.
|
Founded Year | Domain | Location | |
|
Activated dendritic cells are developed for cancer immunotherapy treatments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CytunePharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CytunePharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytunepharma Comparisons
Competitors of CytunePharma
CytunePharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, Revolution Medicines and MiRagen, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cytunepharma
Frequently Asked Questions about CytunePharma
When was CytunePharma founded?
CytunePharma was founded in 2007 and raised its 1st funding round 5 years after it was founded.
Where is CytunePharma located?
CytunePharma is headquartered in Nantes, France. It is registered at Nantes, Pays De La Loire, France.
Is CytunePharma a funded company?
CytunePharma is a funded company, having raised a total of $7.84M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.24M, raised on Jun 01, 2012.
What does CytunePharma do?
Cytune Pharma is focussed on developing immunotherapies for cancer. It is developing therapies based on the reset, restore and activation of the antitumor immune system. Its lead product CYP0150 is a recombinant protein consisting of a human IL-15 linked to the Sushi domain of the human alpha chain receptor which stimulates natural killer and cytotoxic cells, without activating regulatory T cells that dampen the immune response. The candidate along with other immunotherapy strategies, such as checkpoint inhibitors claims to have shown effective and is currently in preclinical trials. It is planning to enter phase 1 trials in 2017. It is also developing conjugated monoclonal antibodies linked to CYP 0150.
Who are the top competitors of CytunePharma?
CytunePharma's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
Who are CytunePharma's investors?
CytunePharma has 3 investors. Key investors include SOTIO, PPF Group, and Starquest Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.